ERBB2 and cancer: Evidence suggests that the main mechanism of HER2 for induction of cell growth, proliferation, and survival in cancers is through phosphatidylinositol‐4,5‐bisphosphate 3‐kinase (PI3K) axis and mitogen‐activated protein kinase (MAPK) cascade, activated by the HER receptor.8